StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3010% above fair value
$7.31−0.40 (-5.19%)

Close on Nov 19, 2026Market cap $234.32MP/E –Yield –

ClearPoint Neuro free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

ClearPoint Neuro's free cash flow for the twelve months ending Sep 30, 2026 was -$48.18M. For fiscal 2025 it was -$24.42M. The highest annual figure on record is -$2.86M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.42M–
FY2024Dec 31, 2024-$9.23M–
FY2023Dec 31, 2023-$14.44M–
FY2022Dec 31, 2022-$16.42M–
FY2021Dec 31, 2021-$12.87M–
FY2020Dec 31, 2020-$7.85M–
FY2019Dec 31, 2019-$2.86M–
FY2018Dec 31, 2018-$4.69M–
FY2017Dec 31, 2017-$6.02M–
FY2016Dec 31, 2016-$5.92M–
FY2015Dec 31, 2015-$8.71M–
FY2014Dec 31, 2014-$7.30M–
FY2013Dec 31, 2013-$7.85M–
FY2012Dec 31, 2012-$7.56M–
FY2011Dec 31, 2011-$6.27M–
FY2010Dec 31, 2010-$7.77M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$20.24M–
Q2 FY2026Jun 30, 2026-$7.23M–
Q1 FY2026Mar 31, 2026-$8.61M–
Q4 FY2025Dec 31, 2025-$12.10M–
Q3 FY2025Sep 30, 2025-$3.32M–
Q2 FY2025Jun 30, 2025-$2.64M–
Q1 FY2025Mar 31, 2025-$6.36M–
Q4 FY2024Dec 31, 2024-$1.51M–
Q3 FY2024Sep 30, 2024-$1.21M–
Q2 FY2024Jun 30, 2024-$2.67M–
Q1 FY2024Mar 31, 2024-$3.84M–
Q4 FY2023Dec 31, 2023-$1.19M–
Q3 FY2023Sep 30, 2023-$2.03M–
Q2 FY2023Jun 30, 2023-$5.40M–
Q1 FY2023Mar 31, 2023-$5.82M–
Q4 FY2022Dec 31, 2022-$3.10M–
Q3 FY2022Sep 30, 2022-$3.92M–
Q2 FY2022Jun 30, 2022-$5.06M–
Q1 FY2022Mar 31, 2022-$4.34M–
Q4 FY2021Dec 31, 2021-$3.59M–
Q3 FY2021Sep 30, 2021-$3.42M–
Q2 FY2021Jun 30, 2021-$3.68M–
Q1 FY2021Mar 31, 2021-$2.17M–
Q4 FY2019Dec 31, 2019-$466.11K–
Q4 FY2018Dec 31, 2018-$583.22K–
Q3 FY2018Sep 30, 2018-$986.42K–
Q2 FY2018Jun 30, 2018-$1.14M–
Q1 FY2018Mar 31, 2018-$1.98M–
Q4 FY2017Dec 31, 2017-$1.75M–
Q3 FY2017Sep 30, 2017-$1.70M–
Q4 FY2016Dec 31, 2016-$1.11M–

More ClearPoint Neuro figures

See a number that looks wrong?